Topics
- Novel approaches in the treatment of relapsed multiple myeloma
- The role of risk stratification and upfront therapies in multiple myeloma
- Novel therapies in the management of Hodgkin lymphoma
- Strategies and controversies of maintenance therapy for multiple myeloma
- Treatment and management options for indolent lymphomas
- Management options for aggressive lymphomas
- Risk stratified therapy of chronic lymphocytic leukemia (CLL)
- Novel treatment options in the management of T-cell lymphomas
- Treatment options in the management of myelodysplastic syndrome (MDS)
- Identify updates in the management of chronic myelogenous leukemia (CML)
- The importance of supportive care in the management of hematological malignancies
- Practice guidelines and its impact on cost and reimbursement issues in the management of hematological malignancies
Who should Attend
Radiation oncologists, hematologists/oncologists, pharmacists, researchers, physician assistants, registered nurses, fellows in training interested in new developments for treatment of hematological malignancies and nurse practitioners.
